Related Experiment Video
Updated: Nov 17, 2025
Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
Rethinking Consent for Stroke Trials in Time-Sensitive Situations: Insights From the COVID-19 Pandemic
Mayank Goyal1,2, Johanna Maria Ospel1,3, Aravind Ganesh1
1Department of Clinical Neurosciences (M.G., J.M.O., A.G., M.M.), University of Calgary, Canada.
Insights
The COVID-19 pandemic complicated informed consent for clinical trials. This paper proposes a framework to adapt consent processes during emergencies while protecting patient autonomy.
Area of Science:
- Bioethics
- Clinical Trials
- Public Health
Background:
- Informed consent is crucial for patient autonomy in healthcare and research.
- The COVID-19 pandemic created significant challenges for obtaining informed consent due to safety measures and increased healthcare demands.
- Delays in patient consent became a major obstacle for numerous clinical trials.
Observation:
- The pandemic necessitated a re-evaluation of traditional informed consent procedures.
- Physical distancing and high physician workload complicated the process of ensuring adequate patient understanding and agreement.
- Existing consent protocols faced unprecedented strain, highlighting potential limitations.
Findings:
- Altering informed consent processes during public health crises may be acceptable under specific conditions.
- A flexible framework with predefined criteria and safeguards is proposed.
- This framework aims to balance the need for timely trial progression with the imperative to uphold patient autonomy.
Implications:
- The proposed framework offers a potential solution for conducting clinical trials during future pandemics or similar emergencies.
- It emphasizes maintaining patient autonomy even when modifying consent procedures.
- This approach could streamline research participation while ensuring ethical standards are met.
Abstract:
Informed consent is a key concept to ensure patient autonomy in clinical trials and routine care. The coronavirus disease 2019 (COVID-19) pandemic has complicated informed consent processes, due to physical distancing precautions and increased physician workload. As such, obtaining timely and adequate patient consent has become a bottleneck for many clinical trials. However, this challenging situation might also present an opportunity to rethink and reappraise our approach to consent in clinical trials. This viewpoint discusses the challenges related to informed consent during the COVID-19 pandemic, whether it could be acceptable to alter current consent processes under these circumstances, and outlines a possible framework with predefined criteria and a system of checks and balances that could allow for alterations of existing consent processes to maximize patient benefit under exceptional circumstances such as the COVID-19 pandemic without undermining patient autonomy.
